Oppenheimer Reaffirms Their Buy Rating on Biomea Fusion (BMEA)
In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Biomea Fusion (BMEA – Research Report), with a price ...
Analysts Conflicted on These Healthcare Names: Zentalis Pharmaceuticals (ZNTL) and Viking Therapeutics (VKTX)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Zentalis Pharmaceuticals (ZNTL – Research ...
Analysts Conflicted on These Healthcare Names: Savara (SVRA) and Zentalis Pharmaceuticals (ZNTL)
According to TipRanks.com, Archila is a 4-star analyst with an average return of 5.4% and a 45.0% success rate. Archila covers the Healthcare sector, focusing on stocks such as Arvinas Holding Company ...
The Manila Times5d
Hudbay Consolidates 100% Ownership in its Copper Mountain Mine
Hudbay (TSX, NYSE: HBM) is a copper-focused critical minerals company with three long-life operations and a world-class pipeline of copper growth projects in tier-one mining jurisdictions of Canada, ...
Arvinas Announces Oral Presentation at 2025 International Conference on Alzheimer’s & Parkinson’s Diseases
Company to highlight first-in-human data from healthy volunteers in both the single-ascending and multiple-ascending dose ...
Oppenheimer Remains a Buy on Zentalis Pharmaceuticals (ZNTL)
Detailed price information for Zentalis Pharmaceuticals Inc (ZNTL-Q) from The Globe and Mail including charting and trades.
Top 3 Health Care Stocks That Are Set To Fly This Month
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.